AreteiaTx

AreteiaTx is a pioneering biotechnology company dedicated to transforming the lives of asthma patients. With a focus on innovative solutions, AreteiaTx is developing the first potential oral drug for eosinophilic asthma, aiming to provide individuals with better control over their condition and their lives.

Located in Research Triangle Park, North Carolina, and with an additional office in Short Hills, New Jersey, AreteiaTx is committed to advancing the field of asthma treatment through cutting-edge research and development. The company's mission is to revolutionize asthma management, offering new hope and improved outcomes for patients worldwide.

AreteiaTx is poised to make a significant impact on the biotechnology landscape. The team is driven by a passion for innovation and a dedication to improving patient care. The company is actively working to expand its reach and ensure its groundbreaking treatments reach those who need them most. We invite the management of AreteiaTx to create a customized and exclusive company showcase and product listing on our platform to further amplify their presence and connect with a wider audience.